Susan Quaggin
Director/Board Member at ABBVIE INC.
Net worth: 213 159 $ as of 2024-05-30
Susan Quaggin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ABBVIE INC. | Director/Board Member | 2023-10-10 | - |
| Independent Dir/Board Member | 2023-10-10 | - | |
Mannin Research, Inc.
 Mannin Research, Inc. BiotechnologyHealth Technology Mannin Research, Inc. develops novel therapeutics for vascular diseases. It also operates a research platform that develops a class of drugs to treat diseases such as glaucoma and cystic kidney disease. The company is headquartered in Toronto, Canada. | Director/Board Member | - | - |
| Chief Tech/Sci/R&D Officer | - | - | |
American Society of Nephrology
 American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC. | Director/Board Member | - | - |
| Feinberg School of Medicine | Corporate Officer/Principal | - | - |
Career history of Susan Quaggin
Statistics
International
| United States | 4 |
| Canada | 2 |
Operational
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Health Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Private companies | 2 |
|---|---|
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC. | Health Services |
Mannin Research, Inc.
Mannin Research, Inc. BiotechnologyHealth Technology Mannin Research, Inc. develops novel therapeutics for vascular diseases. It also operates a research platform that develops a class of drugs to treat diseases such as glaucoma and cystic kidney disease. The company is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Susan Quaggin
- Experience
